RCT Protocol: Emotion Regulation for Eco Anxiety & Eating Concerns in Mexicans Adults

April 10, 2026 updated by: María Libertad Paredes Díaz, Universidad Veracruzana

Emotion Regulation-Based Intervention for Eco-Anxiety and Eating-Related Eco-Concerns in Mexican Adults: Protocol for a Randomized Controlled Trial

The goal of this clinical trial is to evaluate the effect of a group intervention based on emotion regulation as a coping strategy for eco-anxiety and eating-related eco-concerns in Mexican adults. The main questions it aims to answer are:

  • Does the intervention group show a significant decrease in eco-anxiety at the end of the intervention and at the four-month follow-up?
  • Does the intervention group show a significant reduction in eating-related eco-concerns, as well as improvement in emotion regulation and adaptive coping styles?

Researchers will compare the intervention group with the control group to determine whether an intervention based on emotion regulation improves adaptive coping styles.

Participants will:

  • Attend the intervention sessions weekly for 6 weeks.
  • Complete the assessment instruments at three time points: prior to the start of the intervention, at the end of the intervention, and 4 months post-intervention.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Yolanda Campos-Uscanga, PhD
  • Phone Number: 13305 +52 2288418900
  • Email: ycampos@uv.mx

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Individuals aged 18 to 59 years residing in Xalapa, Veracruz, who respond to the participation call.

Exclusion Criteria:

  • Individuals with a known diagnosis of a psychiatric disorder.
  • Individuals are currently receiving psychotherapeutic or psychiatric treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Experimental: Intervention group
Other: Emotional Regulation for Eco Anxiety & Eating Concerns
The program consists of six 90-minute sessions. Each session will be led by a psychologist with expertise in CBT and group interventions, accompanied by a support psychologist with experience in group settings who will be present throughout all sessions. Each session follows this structure: welcome, mindfulness exercise, development of a coping strategy, at-home practice activity, and closing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Eco-Anxiety Scores
Time Frame: From enrollment to the end of treatment at 6 weeks
Measured using the Eco-anxiety Questionnaire (EAQ-Esp). Higher scores indicate greater eco-anxiety. The outcome is the change in scores, specifically whether eco-anxiety scores will decrease or change compared to baseline measurement
From enrollment to the end of treatment at 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Eating-Related Eco-Concerns
Time Frame: From enrollment to the end of treatment at 6 weeks
Measured using the Eating-Related Eco-Concerns Scale (EREC-Esp). Higher scores indicate greater eating-related Eco-Concerns. The outcome is the change in scores will decrease or change compared to baseline measurement
From enrollment to the end of treatment at 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad Veracruzana

Collaborators

University of Washington
Universidad de San Martín de Porres (USMP)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 20, 2026

Primary Completion (Estimated)

May 28, 2026

Study Completion (Estimated)

September 28, 2026

Study Registration Dates

First Submitted

April 10, 2026

First Submitted That Met QC Criteria

April 10, 2026

First Posted (Actual)

April 17, 2026

Study Record Updates

Last Update Posted (Actual)

April 17, 2026

Last Update Submitted That Met QC Criteria

April 10, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • CEI-ISP-UV-R07/2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on To Evaluate the Effect of a Group Intervention Based on Emotion Regulation

Clinical Trials on Emotional Regulation for Eco Anxiety & Eating Concerns

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe